{"task_id": "f264cfa63c1bad55", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 101/464)", "text": "08 [Image/Scan] ---\n\n--- Page 109 [Image/Scan] ---\n\n--- Page 110 ---\n4\nCRITICAL CARE\nSection Editor: Dr. Wendy Sligl\nIntensive Care Issues\nICU ADMISSION CRITERIA\nNEED FOR FREQUENT OR CONTINUOUS MONI\nTORING\npost high risk surgery, high risk for clinical\ndeterioration\nHIGH INTENSITY OF NURSING CARE\nLIFE SUPPORT THERAPY\nmechanical ventilation,\nvasoactive drugs, continuous renal replacement, artifi\ncial liver support\nPREVENTATIVE STRATEGIES\nVENTILATOR ASSOCIATED PNEUMONIA\nremove\nendotracheal tube as soon as possible, orotracheal\nintubation unless contraindicated, hand hygiene, oral\nand dental hygiene (chlorhexidine rinse), semi\nrecumbent\npositioning,\nrotational\nbed\ntherapy,\nsubglottic suctioning, drainage of condensate from\nventilator circuits, minimize gastric acid suppression\ntherapy (proton pump inhibitors) when possible\nGASTROINTESTINAL STRESS ULCERATION\nrisk\nfactors include mechanical ventilation and/or coagulo\npathy. Prophylaxis with H2 blockers (e.g. ranitidine\n50 mg IV q8h or 150 mg PO/NG q12h) preferred unless\nhigh risk as use of proton pump inhibitors is associated\nwith increased risk of ventilator associated pneumonia\nVENOUS\nTHROMBOEMBOLISM\nparticularly\nin\npatients with trauma and prolonged bed rest. Pro\nphylaxis includes heparin SC, LMWH, fondaparinux, or\npneumatic compression stockings\nSEDATION, ANALGESIA, PARALYSIS IN THE ICU\nSEDATION/AMNESIA\npropofol 0.5 mg/kg/h initial\ninfusion, titrate to 0.5 3.0 mg/kg/h by continuous IV\ninfusion, typical infusion range 0 300 mg/h. Appropriate\nforshort termsedation,monitorforacidosisandincreased\nCK with prolonged use, rapid onset, short duration; mid\nazolam0.03mg/kgloadingdose,then0.02 0.1mg/kg/h\nIVinfusion,typicalinfusionrange0 10mg/h,rapidonset,\nshortduration;lorazepam0.5 10mgIVq2 4hPRN,load\nwith 0.5 2 mg q15min, avoid continuous infusion as\npropylene glycol solvent may accumulate. Use for inter\nmediate to prolonged sedation, longer duration than\nmidazolam, most potent amnestic\nANALGESIA\nfentanyl 50 100 mg q5min IV load to\neffect, then 1 4 mg/kg/h by continuous IV infusion,\nSEDATION,ANALGESIA,PARALYSISINTHEICU(CONT\u2019D)\ntypical infusion range 50 300 mg/h, 100\u0002 more\npotent than morphine. Used in patients with hemo\ndynamic instability, rapid onset, short duration;\nmorphine 0.05 mg/kg IV load, then 4 15 mg/h.\nMay cause hypotension due to histamine release;\nhydromorphone 0.5 mg IV initially, then 1 2 mg\nq1h or 0.5 2 mg/h infusion, 5\u0002more potent than\nmorphine\nNEUROMUSCULARBLOCKAGE\nrocuronium0.5mg/\nkg IV PRN, onset 1 min, duration 30 min; pancuro\nnium 0.06 0.15 mg/kg IV PRN, onset 2 3 min, dura\ntion 60 120 min, may run continuous infusion\n0.01 0.05 mg/kg/h, vagolytic effect may cause tachy\ncardia; cisatracurium 0.15 0.2 mg/kg IV PRN, onset\n2 3 min, duration 30 min, may run continuous infu\nsion 3 mg/kg/min, undergoes Hoffman degradation;\nsuccinylcholine 0.5 1.5 mg/kg IV, onset 1 min, dura\ntion \u000310 min, metabolized by pseudocholinesterase,\nmany contraindications\nDIFFERENTIAL DIAGNOSIS FOR WEAKNESS IN THE\nICU\nENCEPHALOPATHY\nhypoxic/ischemic,\nseptic,\nhepatic, uremic, hypoglycemic, iatrogenic (drugs)\nMYELOPATHY\nhypoxic/ischemic, traumatic\nNEUROPATHY\ncritical\nillness\npolyneuropathy,\nGuillain Barre, motor neuron disease, compression,\nhypophosphatemia\nNEUROMUSCULAR JUNCTION\nblocking agents,\nEaton Lambert, myasthenia gravis, hypomagnese\nmia, hypocalcemia, organophosphates, botulism\nMYOPATHY\ncritical\nillness\nmyopathy,\nacute\nnecrotizing myopathy, hypokalemia, hypopho\nsphatemia, hypocalcemia, hypomagnesemia, ster\noid, muscular dystrophy, polymyositis\nPROCEDURES\nRADIAL ARTERIAL LINE INSERTION (NEJM 2006\n354:e13)\n\u0004\nLANDMARK\npalpate\nradial\nartery\nimmediately\nproximal to scaphoid. Insert 20 gauge (48 mm\nlength) catheter at 308\nD. Hui, Approach to Internal Medicine, DOI 10.1007/978 1 4419 6505 9 4,\n\u0002 Springer Science\u00feBusiness Media, LLC 2006, 2007, 2011\n89", "text_length": 3850, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 101/464)", "type": "chunk", "chunk_index": 100, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.378850", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.379577", "status": "complete", "chunks_added": 2}